Mesirow Financial Investment Management Inc. Has $1.88 Million Holdings in CVS Health Corporation (NYSE:CVS)

Key Points

• Mesirow Financial Investment Management Inc. reduced its holdings in CVS Health Corporation by 16.1% in the first quarter, now owning 27,681 shares valued at approximately $1.875 million.
• CVS Health reported a quarterly earnings per share (EPS) of $2.25, exceeding analyst estimates of $1.62, with revenues reaching $94.59 billion.
• The company announced a quarterly dividend of $0.665, representing an annual yield of 4.26%, with a payout ratio of 63.48%.

Mesirow Financial Investment Management Inc. decreased its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 16.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,681 shares of the pharmacy operator's stock after selling 5,329 shares during the period. Mesirow Financial Investment Management Inc.'s holdings in CVS Health were worth $1,875,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Capital World Investors grew its holdings in shares of CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after purchasing an additional 12,819,148 shares in the last quarter. Dodge & Cox boosted its stake in CVS Health by 11.2% in the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after buying an additional 7,075,209 shares in the last quarter. Invesco Ltd. boosted its stake in CVS Health by 30.1% in the fourth quarter. Invesco Ltd. now owns 18,038,089 shares of the pharmacy operator's stock valued at $809,730,000 after buying an additional 4,173,243 shares in the last quarter. Fairfax Financial Holdings Ltd. Can acquired a new stake in CVS Health in the fourth quarter valued at about $121,742,000. Finally, Assenagon Asset Management S.A. boosted its stake in CVS Health by 310.8% in the first quarter. Assenagon Asset Management S.A. now owns 3,523,824 shares of the pharmacy operator's stock valued at $238,739,000 after buying an additional 2,666,029 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Trading Up 0.7%

CVS stock traded up $0.42 during mid-day trading on Friday, reaching $62.52. The company's stock had a trading volume of 11,376,286 shares, compared to its average volume of 8,510,677. The company has a market cap of $79.09 billion, a price-to-earnings ratio of 17.46, a price-to-earnings-growth ratio of 0.89 and a beta of 0.57. The business's 50 day moving average price is $64.56 and its 200 day moving average price is $63.85. The company has a current ratio of 0.80, a quick ratio of 0.63 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.83 earnings per share. On average, equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend is Tuesday, July 22nd. CVS Health's dividend payout ratio (DPR) is 74.30%.

Insider Buying and Selling

In other news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the purchase, the director owned 12,007 shares of the company's stock, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.22% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Jefferies Financial Group lifted their price target on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Morgan Stanley lifted their price target on CVS Health from $80.00 to $82.00 and gave the company an "overweight" rating in a research note on Friday. UBS Group cut their price target on CVS Health from $71.00 to $67.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 22nd. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, Bernstein Bank lowered their price objective on CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research report on Wednesday, July 16th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $75.11.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.